#25-119 Decision on delisting of Diagonal Bio AB from Nordic SME

Report this content

Diagonal Bio AB ("the Company"), whose shares are listed on Nordic SME, issued a press release with information that the Lund District Court have declared the Company bankrupt on December 11, 2025. NGM decided to trade halt the shares on December 11, 2025. For more information, see Market Notice #25-118.

According to paragraph 3.3.2 in Rules for companies whose shares are listed on Nordic SME the exchange may decide to delist the instruments of an issuer if an application for bankruptcy, liquidation of the business, or a decision regarding an equivalent measure has been taken by the Company or filed by a third party with a court or public authority.

With reference to the above, NGM has decided to delist the shares of the Company from Nordic SME with immediate effect. Trading in the Company’s shares will not be resumed.

Information regarding the affected instrument:
Listing name: Diagonal Bio
Exchange symbol: DIABIO
ISIN-code: SE0015961826
CFI-code: ESVUFR
FISN-code: DIAGONALBI/SH
Instrument-ID: H5VY
Last day of trading: 2025-12-11
Market-ID: NSME
Segment-ID: NSSE

 

For more information about this Market Notice, please contact us by e-mail, marketsurveillance@ngm.se or telephone, +46 8 566 390 55.
 

NGM Market Notice Pressroom
https://news.cision.com/ngm-market-notice